Search
Clinical Trials
A company in England has made a test that picks out the compounds from breath that reveal if people have liver disease.
Retatrutide, Eli Lilly's innovative "triple g" drug, is setting new standards in the fight against obesity.
In the ongoing battle against PTSD, a potential new weapon emerges: a nasal spray loaded with neuropeptide Y.
2hr 9mins
Johns Hopkins professor Dr. Matthew Johnson answers 24 huge questions about psychedelics.
Rapamycin is potentially the most powerful anti-aging drug ever discovered. However, due to its unlucky history, few know of it.
Scientists are still figuring out why tirzepatide causes weight loss. One theory is that they “accidentally” created a new hormone.
Researchers have been developing a promising model that can more closely mimic the human body – organ-on-a-chip.
The placebo effect is real. So are the ethical conundrums posed by those who would exploit the latest research advances for profit.
This small phase 1 study suggests that CRISPR-engineered T cells are safe and potentially effective, but there is a long way to go.
The potential new drug is in a class of its own, as it works differently than any other antidepressant on the market.